Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies
Public ClinicalTrials.gov record NCT03877250. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Characterization of Mechanism of Response to PD-1 Blockade in NSCLC: A Pilot Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to attempt to obtain an on-treatment biopsy in participants with non-small cell lung cancer who are receiving standard treatment with a drug that targets the PD-1 or PD-L1 protein.
Study identification
- NCT ID
- NCT03877250
- Recruitment status
- Withdrawn
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Pre-Treatment Biopsy Diagnostic Test
- On-Treatment Biopsy Diagnostic Test
- Biopsy at Disease Progression Diagnostic Test
- Peripheral Blood-Based Studies Diagnostic Test
Diagnostic Test
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 7, 2019
- Primary completion
- Aug 25, 2020
- Completion
- Aug 25, 2020
- Last update posted
- May 14, 2025
2019 – 2020
United States locations
- U.S. sites
- 6
- U.S. states
- 2
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Memoral Sloan Kettering Basking Ridge (Consent and Follow up) | Basking Ridge | New Jersey | 07920 | — |
| Memoral Sloan Kettering Monmouth (Consent and Follow up) | Middletown | New Jersey | 07748 | — |
| Memorial Sloan Kettering Bergen (Consent and Follow up) | Montvale | New Jersey | 07645 | — |
| Memorial Sloan Kettering Cancer Center @ Suffolk (Consent Only) | Commack | New York | 11725 | — |
| Memoral Sloan Kettering Westchester (Consent & Follow Up) | Harrison | New York | 10604 | — |
| Memorial Sloan - Kettering Cancer Center (Consent and follow-up) | New York | New York | 10021 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03877250, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2025 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03877250 live on ClinicalTrials.gov.